Santhera Pharmaceuticals Holding AG (SANN.SW)
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.
14.60+0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-2.0%
The outlook
Santhera Pharmaceuticals Holding AG currently reads as leaning bullish based on mixed vs its moving averages, 55% of the way from its 52-week low to high, avg target +88% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendMixed vs its moving averages
52-week range55% of the way from its 52-week low to high
Price targetAvg target +88% vs current price
Analyst price target
~12-month · 2 analysts27.50average target+88.4% vs now
Now 14.60
Low 25.00High 30.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$216.5M
52-wk high
18.84
52-wk low
9.38
50-day avg
15.58
200-day avg
14.36
Trailing P/E
—